Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenylate kinase 3 pseudogene 3 (AK3P3) is a human pseudogene likely derived from the AK3 gene, which codes for a mitochondrial phosphotransferase enzyme involved in energy metabolism. Pseudogenes like AK3P3 do not encode a functional protein and are considered inactive in terms of cellular enzymatic activity. There are multiple adenylate kinase 3 pseudogenes in the human genome, with AK3P3 being one such non-functional copy. It is not considered a therapeutic target, nor does it have known direct biological functions or clinical significance as an individual locus[4]. AK3P3 is not an active enzyme, receptor, or therapeutic target, but a pseudogene. If you are interested in the active enzyme, the relevant target would be Adenylate kinase 3 (AK3), not the pseudogene variant.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenylate kinase 3 pseudogene 3 (AK3P3).